Supernus Pharmaceuticals’ $450 Million Acquisition of Adamas Pharmaceuticals

Davis Polk advised Lazard as financial adviser to Adamas Pharmaceuticals on the deal while Saul Ewing Arnstein & Lehr represented Supernus.Adamas Pharmaceuticals announced its $450 million acquisition…

This content is for members only.
Login to Read More Join Now
Avatar

Author: Alejandro Girola

This content is for members only.
Login to Read More Join Now